Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William C Dooley

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Plos One|April 30, 2021
Women survive longer than men undergoing cytoreductive surgery and HIPEC for appendiceal cancerNoah S Rozich, Samara E Lewis, Sixia Chen, et al.
Breast Cancer Research : BCR|September 10, 2016
Plasma exosome microRNAs are indicative of breast cancerBethany N Hannafon, Yvonne D Trigoso, Cameron L Calloway, et al.
Oncotargets and Therapy|November 5, 2010
Use of electronic brachytherapy to deliver postsurgical adjuvant radiation therapy for endometrial cancer: a retrospective multicenter studyWilliam C Dooley, John P Thropay, Gary J Schreiber, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 28, 2015
Blocking the adhesion cascade at the premetastatic niche for prevention of breast cancer metastasisShin-Ae Kang, Nafis Hasan, Aman P Mann, et al.
Oncotargets and Therapy|May 10, 2011
Electronic brachytherapy as adjuvant therapy for early stage breast cancer: a retrospective analysisWilliam C Dooley, James C Wurzer, Mohamed Megahy, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 22, 2020
Randomized Phase IIB Trial of the Lignan Secoisolariciresinol Diglucoside in Premenopausal Women at Increased Risk for Development of Breast CancerCarol J Fabian, Seema A Khan, Judy E Garber, et al.
Annals of Surgical Oncology|April 5, 2022
Age-Independent Preoperative Chemosensitivity and 5-Year Outcome Determined by Combined 70- and 80-Gene Signature in a Prospective Trial in Early-Stage Breast CancerPat Whitworth, Peter D Beitsch, James V Pellicane, et al.
JCO Precision Oncology|April 27, 2022
Distinct Neoadjuvant Chemotherapy Response and 5-Year Outcome in Patients With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Tumors That Reclassify as Basal-Type by the 80-Gene SignaturePat W Whitworth, Peter D Beitsch, James V Pellicane, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Plos One|April 30, 2021
Women survive longer than men undergoing cytoreductive surgery and HIPEC for appendiceal cancerNoah S Rozich, Samara E Lewis, Sixia Chen, et al.
Breast Cancer Research : BCR|September 10, 2016
Plasma exosome microRNAs are indicative of breast cancerBethany N Hannafon, Yvonne D Trigoso, Cameron L Calloway, et al.
Oncotargets and Therapy|November 5, 2010
Use of electronic brachytherapy to deliver postsurgical adjuvant radiation therapy for endometrial cancer: a retrospective multicenter studyWilliam C Dooley, John P Thropay, Gary J Schreiber, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 28, 2015
Blocking the adhesion cascade at the premetastatic niche for prevention of breast cancer metastasisShin-Ae Kang, Nafis Hasan, Aman P Mann, et al.
Oncotargets and Therapy|May 10, 2011
Electronic brachytherapy as adjuvant therapy for early stage breast cancer: a retrospective analysisWilliam C Dooley, James C Wurzer, Mohamed Megahy, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 22, 2020
Randomized Phase IIB Trial of the Lignan Secoisolariciresinol Diglucoside in Premenopausal Women at Increased Risk for Development of Breast CancerCarol J Fabian, Seema A Khan, Judy E Garber, et al.
Annals of Surgical Oncology|April 5, 2022
Age-Independent Preoperative Chemosensitivity and 5-Year Outcome Determined by Combined 70- and 80-Gene Signature in a Prospective Trial in Early-Stage Breast CancerPat Whitworth, Peter D Beitsch, James V Pellicane, et al.
JCO Precision Oncology|April 27, 2022
Distinct Neoadjuvant Chemotherapy Response and 5-Year Outcome in Patients With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Tumors That Reclassify as Basal-Type by the 80-Gene SignaturePat W Whitworth, Peter D Beitsch, James V Pellicane, et al.
Pageof 3